Events
Upcoming Events
Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD
Mar 10, 2021 at 6:45 AM EST
Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE Discussion at AD/PD
Mar 10, 2021 at 11:00 AM EST
Evaluation of aducanumab efficacy in early Alzheimer’s disease at AD/PD
Mar 13, 2021 at 6:45 AM EST
Evaluation of aducanumab safety in early Alzheimer’s disease at AD/PD
Mar 13, 2021 at 7:00 AM EST
Evaluation of aducanumab efficacy and safety in early Alzheimer’s disease Discussion at AD/PD
Mar 13, 2021 at 11:30 AM EST
Past Events
Biogen at the Cowen 41st Annual Health Care Conference
Mar 1, 2021
Aducanumab data review and Q&A with Global Alzheimer's Platform
Feb 23, 2021
Q4 and Full Year 2020 Earnings Call Webcast (replay)
Feb 3, 2021
Aducanumab data review and Q&A with Alzheimer's Disease International (replay)
Jan 14, 2021
Biogen at the 39th Annual J.P. Morgan Healthcare Conference (replay)
Jan 11, 2021
Biogen and Sage Collaboration Webcast (replay)
Nov 30, 2020
Aducanumab EMBARK study design and Q&A at CTAD 2020 (replay)
Nov 4, 2020
Q3 2020 Earnings Call Webcast (replay)
Oct 21, 2020
Biogen Reports Q3 2020 Results 232.7 KB
Aducanumab Phase 3 Topline Results at the AAN 2020 Science Highlights (encore virtual presentation replay)
Sep 23, 2020
Aducanumab Phase 3 Topline Results at the 23rd Chinese National Conference of Neurology (encore virtual presentation replay)
Sep 19, 2020
Biogen at the Morgan Stanley Virtual Global Healthcare Conference (replay)
Sep 14, 2020
Biogen at the 61st Annual Meeting of the Japanese Society of Neurology (replay)
Aug 31, 2020
Aducanumab Phase 3 Topline Results at AAIC (encore presentation and Q&A replay)
Jul 29, 2020
Q2 2020 Earnings Call Webcast (replay)
Jul 22, 2020
Biogen to Participate in SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum (replay)
Jun 23, 2020
2020 Annual Meeting of Stockholders (replay)
Jun 3, 2020
Aducanumab Phase 3 Topline Results at AAN (encore virtual presentation replay)
May 18, 2020
This encore virtual presentation replay of the Aducanumab Phase 3 Topline Results was also presented at the 39th Annual Meeting of the Japan Society for Dementia Research on Nov 25, 2020
Biogen at the 2020 World Medical Innovation Forum (replay)
May 11, 2020
Q1 2020 Earnings Call Webcast (replay)
Apr 22, 2020
Aducanumab Phase 3 Topline Results at AAT-AD/PD (encore presentation replay)
Apr 2, 2020
Biogen at the Cowen 40th Annual Health Care Conference (replay)
Mar 2, 2020
Investor Q&A call following CTAD Presentation (replay)
Dec 5, 2019
Aducanumab Phase 3 Topline Results at CTAD (replay)
Dec 5, 2019
Biogen Webcast on ALS Portfolio (replay)
Jun 5, 2019
Biogen Webcast on Multiple Sclerosis Portfolio (replay)
Dec 12, 2018
View Presentation 2.4 MB
Biogen Webcast on R&D Progress Targeting Stroke (replay)
Jun 28, 2018
View Presentation 1.9 MB